Main News

09/22/2021

IVI’s Statement for the Global COVID-19 Summit: Ending the Pandemic and Building Back Better

09/27/2021

Enrollment begins for Sanofi and GSK’s Phase 3 efficacy trial of COVID-19 vaccine candidate in Nepal, led by IVI

International Vaccine Institute (IVI) will lead the clinical trial in Nepal to assess the safety, efficacy and immunogenicity of an adjuvanted recombinant-protein COVID-19 vaccine candidate Phase 3 international clinical trial includes volunteers from several countries, including sites in the US, Asia, Africa and Latin America […]
09/28/2021

The International Vaccine Institute, Texas Children’s Hospital, and Baylor College of Medicine partner for collaborative vaccine research

Sept. 28, 2021 – SEOUL, South Korea, and HOUSTON, Texas, USA – The International Vaccine Institute (IVI), the Texas Children’s Hospital Center for Vaccine Development, and Baylor College of Medicine’s National School of Tropical Medicine signed a Memorandum of Understanding to promote and further academic […]
10/07/2021

IVI’s 2021 State Forum highlights opportunities to bridge global vaccine gaps

Until Everyone Is Safe: Global Vaccine Needs and IVI’s Capabilities was livestreamed on October 7, 2021 at 16:00 Korea Standard Time, and a recording of the event is available here.         October 7, 2021, SEOUL, Republic of Korea — The International Vaccine […]